Singderm® Modified Sodium Hyaluronate Gel for Injection is a CE-approved monophasic hyaluronic acid (HA) dermal filler with 0.3% lidocaine, developed for facial tissue augmentation and volume restoration.
Formulated with 24 mg/mL of non-animal hyaluronic acid produced through bacterial fermentation, Singderm® combines high HA concentration, optimized viscoelasticity and patented SingLink® cross-linking technology to provide structural support and smooth integration with surrounding tissue.
The product is indicated for facial tissue augmentation by injection into areas where restoration is required, including volume loss and facial morphological asymmetry. Depending on the treatment area and clinical requirements, Singderm® is designed for injection into the mid to deep dermis or subcutaneous layer.
Singderm® is supplied in 1 mL, 2 mL and 10 mL specifications and has been exported to more than 30 countries and regions worldwide.
Audited Supplier 
){kind=link}